BCR/ABL-induced leukemogenesis causes phosphorylatiorm of Hef1 and its association with Crkl

BCR/ABL is considered responsible for the development of Philadelphia chromosome-positive leukemia, Experimental animal models, such as transgenic mice, have demonstrated unambiguously that Bcr/Abl is capable of inducing leukemogenesis, The adaptor molecule Crkl is a major in vivo substrate of the deregulated Bcr/Abl tyrosine binase and functions as a molecular link with other signaling proteins, While associated in vivo with Bcr/Abl through its SH3 domain, Crkl can interact simultaneously via its SH2 domain with other tyrosine-phosphorylated proteins. Here we report the identification of prominently tyrosine-phosphorylated proteins with a molecular mass of approximately 110 kDa, which bind specifically to the Crkl SH2 domain in leukemic tissues of P190BCR/ABL transgenic mice. We demonstrate that these proteins are identical to Hef1/Cas-L, which is related to p130(Cas). The proto-oncoprotein p120(Cbl) and Hef1, but not p130(Cas), were detectably phosphorylated on tyrosine in P190Bcr/Abl-expressing leukemic cells and were found in complex with Crkl, showing the existence of protein complexes in P190Bcr/Abl leukemic cells, consisting of P190Bcr/Abl, Crkl, and Hef1 or p120(Cbl). This supports a model in which Crkl acts as mediator between Bcr/Abl and downstream effecters, Since Hef1 is involved in the beta(1)-integrin signaling pathway, our study demonstrates that Bcr/Abl could specifically interfere with normal beta(1)-integrin signaling.